Stocks · Healthcare · Medical - Diagnostics & Research
Guardant Health, Inc. GH
$177.80 +1.75% Close, Oct 2, 2026 · NASDAQ · Market cap $23.86B
Strong growthStrong trend
Next earnings report: Oct 28, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -39.7% from -55.6% a year earlier.
- Over the past year the stock returned +183.8%, ahead of the S&P 500 by 168.7 percentage points.
- Revenue over the last four quarters was $1.18B, up 42.7% from a year earlier, accelerating from 39.6% a quarter earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 19%
- Revenue growth, 3-year CAGRTop 22%
- Revenue growth accelerationTop 22%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 42%
- Gross marginTop 50%
- Operating marginBottom 37%
- Accruals (lower is better)Top 24%
- Interest coverBottom 13%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 36%
- Free-cash-flow yieldTop 39%
- EBITDA / enterprise valueTop 42%
- Sales / enterprise valueBottom 20%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 9%
- 6-month returnTop 11%
- 1-year return vs S&P 500Top 6%
- Distance from 52-week highTop 3%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 27%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 21%
- Upside to consensus price targetBottom 21%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 27%
- Maximum drawdown, 3 yearsTop 20%
- Beta vs S&P 500 (lower is better)Bottom 39%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 39.6% | 42.7% | ↑ |
| Gross margin | 62.8% | 65.0% | ↑ |
| Operating margin | -55.6% | -39.7% | ↑ |
| FCF margin | -32.8% | -20.3% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 42.7% | 39.6% | ↑ | Top 19% |
| Gross margin | 65.0% | 62.8% | ↑ | Top 50% |
| Operating margin | -39.7% | -55.6% | ↑ | Bottom 37% |
| Net margin | -38.3% | -49.9% | ↑ | — |
| Free-cash-flow margin | -20.3% | -32.8% | ↑ | — |
| Return on invested capital | -29.3% | — | Bottom 42% | |
| Revenue growth, 3-year CAGR | 29.8% | — | Top 22% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -14.0%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 16.2%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -32.0 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -97.6×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.23%
- Shareholder yield
- -0.23%
- Share count change, 1 year
- +6.4%
- Share count change, 3-year CAGR
- +6.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 30, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 2 of 8
- Average EPS surprise, last 4
- -11.9%
- Average 2-day reaction, last 8
- +1.6%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $200.07
- Target vs current price
- +12.5%
- Analysts with a rating
- 31
- Share rating Buy or Strong Buy
- 97%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 30, 2026 | -18.1% | +5.7% | +13.3% | +18.6% | — |
| May 7, 2026 | -5.5% | +0.0% | +6.7% | +44.2% | +72.2% |
| Feb 19, 2026 | -30.4% | -1.0% | -11.3% | -18.8% | -8.2% |
| Oct 29, 2025 | +6.3% | +3.9% | +41.0% | +56.4% | +64.9% |
| Jul 30, 2025 | -8.0% | +4.3% | +6.6% | +46.4% | +57.0% |
| Apr 30, 2025 | +1.3% | -4.6% | -15.3% | -22.9% | -10.3% |
| Feb 20, 2025 | -20.0% | -3.3% | -11.9% | -5.6% | -17.4% |
| Nov 6, 2024 | -60.0% | +7.5% | +26.4% | +62.0% | +100.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 30, 2026 | -$0.90 | -$0.76 | -18.1% | $335.0M |
| May 7, 2026 | -$0.85 | -$0.81 | -5.5% | $301.7M |
| Feb 19, 2026 | -$1.00 | -$0.77 | -30.4% | $281.3M |
| Oct 29, 2025 | -$0.74 | -$0.79 | +6.3% | $265.2M |
| Jul 30, 2025 | -$0.80 | -$0.74 | -8.0% | $232.1M |
| Apr 30, 2025 | -$0.77 | -$0.78 | +1.3% | $203.5M |
| Feb 20, 2025 | -$0.90 | -$0.75 | -20.0% | $201.8M |
| Nov 6, 2024 | -$0.88 | -$0.55 | -60.0% | $191.5M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 20.71× | — | — | Bottom 20% |
| Free-cash-flow yield | -1.01% | — | — | Top 39% |
| Earnings yield | -1.96% | — | — | Top 36% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 15
- Days above the 200-day average
- 121
- 50-day average slope (20 days)
- +3.9%
- 200-day average slope (20 days)
- +5.9%
- Distance from 50-day average
- +7.5%
- Distance from 200-day average
- +43.5%
- RSI (14)
- 58.5
- Relative volume
- 0.91×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 43.3%
- Volatility vs own 5-year history
- 2th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.31
- Correlation with S&P 500
- 0.30
- Current drawdown from 1-year high
- -2.9%
- Maximum drawdown, 3 years
- -46.5%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 12, 2021 | Apr 19, 2024 | -91.0% | 800 days | 603 days (Sep 17, 2026) |
| Nov 5, 2020 | Nov 16, 2020 | -11.1% | 7 days | 8 days (Nov 27, 2020) |
| Sep 25, 2020 | Oct 21, 2020 | -10.6% | 18 days | 10 days (Nov 4, 2020) |
| Dec 22, 2020 | Dec 29, 2020 | -10.5% | 4 days | 6 days (Jan 7, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $23.86B
- EPS, diluted (TTM)
- -$3.49
- Revenue (TTM)
- $1.18B
- 52-week range
- $60.45 – $183.51
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $373.7M | $449.5M | $563.9M | $739.0M | $982.0M |
| Gross profit | $250.7M | $293.2M | $336.9M | $449.2M | $633.0M |
| Operating income | -$411.0M | -$544.4M | -$564.7M | -$443.6M | -$437.2M |
| Net income | -$405.7M | -$654.6M | -$479.4M | -$436.4M | -$416.3M |
| EPS (diluted) | -$4.00 | -$6.41 | -$4.28 | -$3.56 | -$3.32 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $191.5M | $201.8M | $203.5M | $232.1M | $265.2M | $281.3M | $301.7M | $335.0M |
| Net income | -$107.8M | -$111.0M | -$95.2M | -$99.9M | -$92.7M | -$128.5M | -$112.1M | -$120.1M |
| EPS (diluted) | -$0.88 | -$0.90 | -$0.77 | -$0.80 | -$0.74 | -$1.00 | -$0.85 | -$0.90 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$209.0M | -$309.5M | -$325.0M | -$239.9M | -$184.8M |
| Capital expenditure | -$75.0M | -$77.5M | -$20.5M | -$35.1M | -$48.3M |
| Free cash flow | -$284.1M | -$386.9M | -$345.5M | -$274.9M | -$233.1M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $0 | $0 | $493.1M | $14.8M | $332.8M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $1.05B
- Total assets
- $1.91B
- Total liabilities
- $2.14B
- Total debt
- $1.70B
- Net debt
- $643.5M
- Shareholders’ equity
- -$222.9M
As of Jun 30, 2026 (filed Jul 30, 2026).
Short interest
- Shares sold short
- 11,018,331
- Days to cover
- 6.59
- Change vs previous report
- -0.3%
FINRA short interest, settlement date Sep 15, 2026.